References
- Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465.
- McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635–2645.
- Flodgren G, Hall AM, Goulding L, et al. Tools developed and disseminated by guideline producers to promote the uptake of their guidelines. Cochrane Database Syst Rev. 2016;8:Cd010669.
- Cornford P, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on prostate vancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol. 2016;71(4):630–642.
- Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2016;71(4):618–629.
- AUA, https://www.auanet.org/education/clinical-practice-guidelines.cfm. 2013–2018.
- KCE, https://kce.fgov.be/publication/report/a-national-clinical-practice-guideline-on-the-management-of-localised-prostate-ca#.WAcn49y1kfp. 2013.
- Duodecim, [Update on current care guideline: prostate cancer]. Duodecim. 2014;130:1666–1667.
- de Reijke TM, Battermann JJ, van Moorselaar RJ, et al. [Practice guideline 'Prostate cancer: diagnosis and treatment']. Ned Tijdschr Geneeskd. 2008;152:1771–1775.
- NICE, https://www.nice.org.uk/guidance/cg175. 2014.
- NPCR, www.npcr.se/rapporter. 2017.
- Socialstyrelsen, Nationella riktlinjer fo¨r bro¨st-, kolorektal- och prostatacancer www.socialstyrelsen.se. 2007.
- Tomic K, Berglund A, Robinson D, et al. Capture rate and representativity of the national prostate cancer register of Sweden. Acta Oncol. 2015;54:158–163.
- Tomic K, Sandin F, Wigertz A, et al. Evaluation of data quality in the national prostate cancer register of Sweden. Eur J Cancer. 2015;51:101–111.
- Tomic K, Westerberg M, Robinson D, et al. Proportion and characteristics of men with unknown risk category in the national prostate cancer register of Sweden. Acta Oncol. 2016;55:1461–1466.
- Van Hemelrijck M, Garmo H, Wigertz A, et al. Cohort Profile: the national prostate cancer register of Sweden and prostate cancer data base Sweden 2.0. Int J Epidemiol. 2013;42:956–967.
- Berglund A, Garmo H, Tishelman C, et al. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol. 2011;185:833–839.
- Bratt O, Folkvaljon Y, Loeb S, et al. Upper limit of cancer extent on biopsy defining very low-risk prostate cancer. BJU Int. 2015;116:213–219.
- Loeb S, Berglund A, Stattin P. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer. J Urol. 2013;190:1742–1749.
- Loeb S, Folkvaljon Y, Curnyn C, et al. Uptake of active surveillance for very-low-risk prostate cancer in Sweden. JAMA Oncol. 2017;3(10):1393–1398. doi:10.1001/jamaoncol.2016.3600.
- Bjorklund J, Folkvaljon Y, Cole A, et al. Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study. BJU Int. 2016;118:302–306.
- Fridriksson J, Gunseus K, Stattin P. Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the national prostate cancer register (NPCR) of Sweden. Scand J Urol Nephrol. 2012;46:326–331.
- Morgia G, Russo GI, Tubaro A, et al. Patterns of prescription and adherence to European Association of Urology guidelines on androgen deprivation therapy in prostate cancer: an Italian multicentre cross-sectional analysis from the choosing treatment for prostate cancer (CHOICE) study. BJU Int. 2016;117:867–873.
- Alcaraz A, Burgos FJ, Cozar JM, et al. Prostate cancer in Spain: from guidelines to clinical practice. BJU Int. 2011;108:61–66.
- Damiani G, Basso D, Acampora A, et al. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. Prev Med. 2015;81:281–289.
- Chaillet N, Dube E, Dugas M, et al. Evidence-based strategies for implementing guidelines in obstetrics: a systematic review. Obstet Gynecol. 2006;108:1234–1245.
- Stattin P, Sandin F, Sandback T, et al. Dashboard report on performance on select quality indicators to cancer care providers. Scand J Urol. 2016;50:21–28.
- McGlynn EA, Adams JL, Kerr EA. The quest to improve quality: measurement is necessary but not sufficient. JAMA Intern Med. 2016;176:1790–1791.